Ultragenyx Pharmaceutical | RARE - Vermögenswerte

Aktienkurs
23.30
Täglich Wechseln
-0.61 -2.55%
Monatlich
4.91%
Jährlich
-31.75%
Q2 Prognose
22.66




Vermögenswerte Veränderung Datum
Acadia Pharmaceuticals USD 1.56B 233.42M 2025-12
Agios Pharmaceuticals USD 1.3B 88.48M 2025-12
Alnylam Pharmaceuticals USD 4.97B 114.67M 2025-12
BioCryst Pharmaceuticals USD 514.16M 67.73M 2025-12
BioMarin Pharmaceutical USD 7.59B 20.85M 2025-12
Esperion Therapeutics USD 465.89M 101.87M 2025-12
Immunic USD 40.7M 20.72M 2025-09
Insmed USD 2.26B 96.18M 2025-12
Ionis Pharmaceuticals USD 3.52B 490.91M 2025-12
Karyopharm Therapeutics USD 108.42M 12.18M 2025-12
Kyowa Hakko Kirin JPY 1.11T 30.41B 2025-12
MacroGenics USD 256.85M 13.92M 2025-12
Moderna USD 12.34B 203M 2025-12
Neurocrine Biosciences USD 4.63B 365.8M 2025-12
PTC Therapeutics USD 2.9B 255.07M 2025-12
Puma Biotechnology USD 202.86M 7.95M 2025-09
Regeneron Pharmaceuticals USD 40.56B 389.3M 2025-12
Sarepta Therapeutics USD 3.35B 143.73M 2025-12
Ultragenyx Pharmaceutical USD 1.53B 341.56M 2025-12
Vertex Pharmaceuticals USD 25.64B 780.7M 2025-12
Xoma USD 263.15M 39.7M 2025-09